13
May

06:00 PM PDT

No One Has Enough Data: Building the Federated Ecosystem
for Next-Generation Drug Discovery

STK Steakhouse San Diego

What to expect

Timely information, interactive format

Despite unprecedented advances in AI and computational sciences, the pace and cost of bringing new therapies to patients remain stubbornly high. One fundamental constraint is increasingly clear: no single organization possesses sufficient data diversity, scale, or longitudinal depth to fully model the behavior of drug modalities.

Federated learning offers a path forward. By enabling models to be trained across institutions without exposing sensitive data, organizations can collaborate while preserving intellectual property, regulatory compliance, and competitive advantage. Yet technology alone is not enough. Real progress requires new governance models, incentive structures, partnerships, and cultural shifts across the biopharmaceutical ecosystem. This strategy dinner convenes Drug Discovery leaders who have a deep understanding of the importance of data and how to leverage technology to maximize their potential.

Topics include privacy-preserving computation, trusted data infrastructure, precompetitive collaboration models, and the operational realities of cross-organizational AI. Together, participants will examine whether federated approaches can meaningfully reduce the traditional 10-year, multi-billion-dollar path to drug development — and what it will take to move from isolated innovation to collective intelligence.

Our Agenda

19:30 – 20:30

Roundtable Tracks

21:30 – 22:30

Roundtable Tracks

Why you should attend

This exclusive Strategy Dinner is designed for senior leaders and strategic decision-makers at the forefront of drug discovery, data science, and pharmaceutical innovation. It brings together a carefully curated group of executives, technical leaders, and thought partners from across the life sciences ecosystem who are shaping the future of cross-organization collaboration and data-driven R&D.
Ideal attendees include:
Heads of Drug Discovery & Preclinical Development
Leaders responsible for steering discovery pipelines, adopting next-generation technologies, and breaking down barriers to accelerate candidate selection.
Data Strategy, AI/ML & Informatics Leaders
Senior professionals tasked with architecting data ecosystems, implementing advanced analytics, and scaling federated or cross-enterprise AI initiatives.
R&D and Technology Executives
Directors and VPs overseeing digital transformation, scientific innovation, and the integration of computational platforms across complex R&D workflows.
Strategic Collaborators & Innovation Partners
Decision-makers from biotech, pharma, and research institutions who are exploring precompetitive models, federated data frameworks, and novel governance structures to drive collective impact.
Thought Leaders in Scientific Software & Analytics
Experts focused on the intersection of technology, science, and operational execution, including leaders who influence tool adoption and digital strategy at an organizational level.
Attendance is limited to ensure meaningful, high-value dialogue in an intimate roundtable format, enabling participants to share actionable insights, benchmark strategies, and build long-lasting professional connections.

Meet Our Facilitators

David Gosalvez, Ph.D

Chief Strategy Officer-Signals Revvity Signals Software

<p>With 25 years of experience in scientific software and analytics, David Gosalvez brings a rare combination of technical and domain expertise with broad knowledge across scientific use cases. He is a passionate advocate for improving the efficiency and quality of science via innovative software solutions. As head of Product Strategy, David works with scientists and IT across pharma and chemical industry to set the direction of the Revvity Signals Informatics portfolio. He also works with other scientific software vendors to integrate complimentary capabilities and AI/ML models into our solutions. As Director of Cheminformatics, he was responsible for the sustained growth of ChemDraw and Spotfire Lead Discovery. Previously, David headed the interdisciplinary Science & Technology team chartered with creating the novel data management technologies that underpinned Revvity Signals platform. David also served as Executive Director of Application Development at CambridgeSoft where he brought to market the Oracle Chemistry Cartridge and ChemBioOffice Enterprise Suite.</p>

Gregg Spivey

Executive Director, AI/ML Partnerships Eli Lilly and Company

More about Revvity

More information

Revvity Signals Software provides an extensive range of scientific solutions, empowering researchers and pharmaceutical pioneers worldwide. Our cutting-edge technology simplifies processes, speeds up experiments, and prioritizes promising compounds, redefining drug discovery. The Signals Research Suite, our flagship solution, streamlines R&D workflows with data capture, collaboration, data processing, and data-driven analytics. It includes i Signals Notebook, the only cloud-native electronic lab notebook with ChemDraw®, Spotfire® powered advanced analytics, as well as next-gen data management. In addition, we have recently introduced Signals Synergy which is designed to substantially enhance collaboration, project management, and data exchange between sponsors and CROs.

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Clinical Trials Revvity

Revvity – AI with Purpose: Strategy-First Innovation Across Drug Discovery 2025

No One Has Enough Data: Building the Federated Ecosystem for Next-Generation Drug Discovery

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2012%2016'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >STK Steakhouse San Diego

Timely information, interactive format

Our Agenda

Registration, Networking & Cocktails

Welcome & Opening Remarks

Roundtable Discussion

Roundtable Tracks

Dinner

Roundtable

Roundtable Tracks

Coffee & Closing Remarks

Why you should attend

Meet Our Facilitators

David Gosalvez, Ph.D

Gregg Spivey

More about Revvity

Further Information

Here To Help

Select days you wish to attend You can add multiple days

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

ENT

Neurology

Urology

Gastroenterology

Oncology

Vaccines

Haematology

Ophthalmology

Thrombosis

Rare Diseases

This is required field*

0-10

10-50

50-100

100-500

500+

This is required field*

This is required field*

Under £100,000

£100,000 - £500,000

£500,000 - £1,000,000

£1,000,000 - £5,000,000

£5,000,000 - £10,000,000

£10,000,000 +

This is required field*

This is required field*

No One Has Enough Data: Building the Federated Ecosystem
for Next-Generation Drug Discovery

STK Steakhouse San Diego